Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Planned sale Chief Commercial Officer sold 1,958 shares at an average $553.11 ($1,082,986)
  2. 4 Planned sale Director sold 8,500 shares at an average $520.96 ($4,428,198)
  3. 4 Open-market sale Director sold 16,575 shares at an average $484.30 ($8,027,354)
  4. 4 Open-market sale President and CEO sold 7,279 shares at $445.63 ($3,243,741)
  5. 4 Planned sale President and CEO sold 7,616 shares at an average $400.18 ($3,047,756)
  6. 4 Open-market buy Director bought 97,065 shares at an average $380.58 ($36,941,197)
  7. 4 Open-market buy Director bought 68,618 shares at an average $364.04 ($24,979,827)
  8. 4 Planned sale General Counsel sold 1,304 shares at an average $367.81 ($479,627)
  9. 4 Open-market sale Director sold 10,000 shares at an average $365.20 ($3,652,009)
  10. 4 Planned sale Director sold 129,172 shares at an average $370.24 ($47,825,149)
  11. 4 Planned sale Director sold 46,808 shares at an average $355.31 ($16,631,386)
  12. 4 Planned sale Director sold 46,463 shares at an average $355.32 ($16,509,032)
  13. 4 Grant or award Director acquired 967 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Planned sale Director sold 1,000 shares at $350.01 ($350,005)
  16. 4 Planned sale Director sold 1,400 shares at $350.03 ($490,044)
  17. 4 Planned sale Director sold 28,876 shares at an average $353.19 ($10,198,844)
  18. 4 Planned sale Director sold 29,101 shares at an average $353.19 ($10,278,098)
  19. 4 Grant or award Director acquired 715 shares (grant or award)
  20. 4 Grant or award Director acquired 715 shares (grant or award)

Page 3 of 29 · 564 filings